Quanterix (QTRX) stock
QTRX's Quality Score fell 2 points on Fri, Oct 30, to -7. Its volume picked back up (2 chart checks stopped).
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Key facts on QTRX
| Since its Nov 2021 high | Down 95% |
| Latest filing | 10-Q, Aug 10 |
QTRX in the news
TodayWith its group.
QTRX catalysts
After its last 4 reports it closed -16.5% on average, higher 0 of 4 times.
Why QTRX scores -7
Poorfor quality, not price, 1 of 14 chart checks firingWhat the Quality Score means
- +1Chart checks 1 of 14 firing right now, one point each
- −3Long-term trend below a falling 200-day average, down over one year, down over two years
- Size subtracts
- Profit subtracts
- Dilution subtracts
- Volatility subtracts
- Cash flow subtracts
Here is what Pro members see.
- Prices refresh every 2.5 seconds during market hours.
- Optional alerts by push, email, or the bell.
- Add it to your Home Screen and it opens like an app.
QTRX has 1 of 14 chart checks firing
QTRX RSI today: 42.7, below its 50-day and 200-day averages
- RSI 1442.7
- MACD (12, 26, 9)Below signal
- 50-day average$2.98
- 200-day average$3.84
- 50/200 crossDeath cross
- ADX 1416.1
- Support$2.67
- Resistance$2.83
- 52-week high$8.77
- 52-week low$2.15
- Chart patternNone
- Bollinger Bands (20, 2)Inside
- Volume1.1x
The deep dive on QTRX
- What it does and how it makes money
- Where it stands
- What changed in its filingsFiled figures, Jun 30, 2026SEC filing · Mar 2, 2026
- Who holds and trades it
How QTRX ranks in Life Science Tools
QTRX is #15 of 15 by Quality Score among Laboratory Analytical Instruments.
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| 15 |
When does QTRX report earnings, and what happens after?
Reports Mon Nov 9, before the open (in 7 days). Confirmed.
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
What QTRX reported on Aug 10, 2026
The quarter
The figures are not read from the release yet.
Where the sales came from
QTRX's results filing gives no sales by line in a table we read.
The outlook
| Measure | Figure |
|---|---|
| Revenue | $142.00 |
In the company's words
“The company expects to end the year with no debt.”
From its results filing (SEC filing · Aug 10)
The numbers
- $149M
- today
- $153M
- up 22% on the year
- -$81.7M
- last 12 months
Sales grew 10% a year over 5 years, fiscal 2020 to 2025.
Its share count grew 7.6% a year over 5 years.
| Reported | Gap | Reaction | 5 sessions |
|---|---|---|---|
| Aug 10, 2026 | -42.9% | -40.0% | -35.7% |
| May 6, 2026 | -4.3% | -16.4% | -12.5% |
| Mar 2, 2026 | -4.9% | -7.3% | -19.4% |
QTRX sales and profit by year
Sales grew in six of the last seven years, to $139M in 2025. It lost money in each of the eight years.
Insiders trading QTRX
QTRX insider trades
2 insiders bought $296K across 3 filings in the last 6 months. No open-market sales on record. The newest:
QTRX's officers and directors
Officers and directors with a Form 4 in the last 12 months.
Which ETFs hold QTRX?
In ETFs: QTRX is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.
About Quanterix
Quanterix Corp is a life sciences company accelerating biomarker breakthroughs from discovery to diagnostics using ultra-sensitive translational research and spatial biology instruments, consumables, and services. The company sells proprietary instruments and related consumables to research laboratories, contract research organizations (CROs), academic institutions, and bio-pharmaceutical companies, and provides contract research services and clinical laboratory testing services, including four Laboratory Developed Tests (LDTs), through its Accelerator Laboratory. Its products include Simoa, Assay Kits, LDTs & Assay Services, Simoa p-Tau 217, Simoa NfL LDT, Simoa p-Tau 181 LDT, and SP-X Imaging and Analysis System. Geographically, it operates in North America, EMEA, and the Asia Pacific.
What Quanterix says it competes with
“We compete with both established and development-stage life science companies that design, manufacture, and market instruments for proteomics discovery and clinical research applications.”
QTRX's score card
Pro members see every line of every stock's score.
- What would turn QTRX's score around: 9 things
- 1 more filing explained, a plain line each
- Real-time prices, no delay
Straight Answers
Is QTRX a good stock to buy? What its Quality Score says
QTRX scores -7 today, which Breakaway calls Poor. It is #15 of 15 in Laboratory Analytical Instruments by Quality Score, with 1 of 14 chart checks firing. Shares: 21.3% more than a year ago (to Jun 30). Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
What is QTRX's Quality Score?
QTRX scores -7 today, which Breakaway calls Poor (below zero). That is #15 of 15 in Laboratory Analytical Instruments by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind QTRX's -7.
Are insiders buying QTRX?
2 insiders bought $296K across 3 filings in the last 6 months. No open-market sales on record. The newest is William P. Donnelly, Director, who bought $212K on Aug 13. Every filing, with the scored weight, for Pro members.
Are the prices delayed?
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.